The Therapeutic Goods Administration approves the usage of the Pfizer-BioNTech COVID-19 vaccine as booster dose for people aged above 18, which can be administered at least six months after received their second dose.
The Therapeutic Goods Administration approves the usage of the Pfizer-BioNTech COVID-19 vaccine as abooster dose for people overtheage of 18yearsold, which can be administered at least six months after the second dose.